Skip to main content
Premium Trial:

Request an Annual Quote

Bio-Rad, Institut Pasteur Extend Alliance Through End of Decade

NEW YORK, Jan. 4 (GenomeWeb News) - Bio-Rad Laboratories and the Institut Pasteur have extended their cooperation an additional four years, Bio-Rad said today.

 

The agreement, signed in Paris last month, gives Bio-Rad exclusive commercialization rights to Pasteur's research developments in the areas of virology, microbiology, physiology, biochemistry, parasitology and mycology, Bio-Rad said.

 

Norman Schwartz, president of the Hercules, Calif.-based company, said that Institut Pasteur "provides important innovations affecting blood virus testing," and that the institute's research is "closely aligned" with Bio-Rad's goal to supply the healthcare community with diagnostic tools.  

 

Bio-Rad and Pasteur have been collaborating since 1990, the company said.

 

Financial details of the agreement were not dislosed.

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.